Literature DB >> 32503899

Muscle biopsy: what and why and when?

Jon Walters1, Atik Baborie2.   

Abstract

Skeletal muscle biopsy remains an important investigative tool in the diagnosis of a variety of muscle disorders. Traditionally, someone with a limb-girdle muscle weakness, myopathic changes on electrophysiology and raised serum creatine kinase (CK) would have a muscle biopsy. However, we are living through a genetics revolution, and so do all such patients still need a biopsy? When should we undertake a muscle biopsy in patients with a distal, scapuloperoneal or other patterns of muscle weakness? When should patients with myositis, rhabdomyolysis, myalgia, hyperCKaemia or a drug-related myopathy have a muscle biopsy? What does normal muscle histology look like and what changes occur in neurogenic and myopathic disorders? As with Kipling's six honest serving men, we hope that by addressing these issues we can all become more confident about when to request a muscle biopsy and develop clearer insights into muscle pathology. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  MUSCLE DISEASE

Mesh:

Substances:

Year:  2020        PMID: 32503899     DOI: 10.1136/practneurol-2019-002465

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  3 in total

1.  Mathematical modelling of oxygen transport in a muscle-on-chip device.

Authors:  David Hardman; Manh-Louis Nguyen; Stéphanie Descroix; Miguel O Bernabeu
Journal:  Interface Focus       Date:  2022-08-12       Impact factor: 4.661

Review 2.  Potential Satellite Cell-Linked Biomarkers in Aging Skeletal Muscle Tissue: Proteomics and Proteogenomics to Monitor Sarcopenia.

Authors:  Diego Fernández-Lázaro; Evelina Garrosa; Jesús Seco-Calvo; Manuel Garrosa
Journal:  Proteomes       Date:  2022-08-19

3.  Muscle Biopsy: A Requirement for Precision Medicine in Adult-Onset Myopathy.

Authors:  Meng-Ju Wu; Wei-An Liao; Po-Yu Lin; Yuan-Ting Sun
Journal:  J Clin Med       Date:  2022-03-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.